Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001453687-25-000075
Filing Date
2025-04-28
Accepted
2025-04-28 16:42:02
Documents
20
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 DEF 14A rnac-20250428.htm   iXBRL DEF 14A 904255
6 rnac-20250428_g1.jpg GRAPHIC 1268513
7 rnac-20250428_g2.jpg GRAPHIC 226650
8 rnac-20250428_g3.jpg GRAPHIC 459565
9 rnac-20250428_g4.jpg GRAPHIC 256709
  Complete submission text file 0001453687-25-000075.txt   6823007

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rnac-20250428.xsd EX-101.SCH 2923
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rnac-20250428_def.xml EX-101.DEF 3528
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rnac-20250428_lab.xml EX-101.LAB 4226
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rnac-20250428_pre.xml EX-101.PRE 2585
22 EXTRACTED XBRL INSTANCE DOCUMENT rnac-20250428_htm.xml XML 163693
Mailing Address 7495 NEW HORIZON WAY FREDERICK MD 21703
Business Address 7495 NEW HORIZON WAY FREDERICK MD 21703 301-348-8698
Cartesian Therapeutics, Inc. (Filer) CIK: 0001453687 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37798 | Film No.: 25881123
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)